Puma Biotech (NASDAQ: PBYI) reported Q3 EPS of ($1.36), $1.13 better than the analyst estimate of ($2.49). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $3.74 million.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.